ACM
RCKT icon

Aquatic Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Aquatic Capital Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-58,166
Closed -$208K – 1644
2026
Q1 		$208K Buy
+58,166
New +$231K 0.01% 980
2024
Q3 		– Sell
-3,200
Closed -$68.9K – 1469
2024
Q2 		$68.9K Sell
3,200
-9,900
-76% -$227K ﹤0.01% 966
2024
Q1 		$353K Buy
+13,100
New +$372K 0.01% 630
2023
Q3 		– Sell
-2,000
Closed -$40K – 1578
2023
Q2 		$40K Buy
+2,000
New +$40.4K ﹤0.01% 1033
2022
Q4 		– Sell
-5,200
Closed -$83K – 1744
2022
Q3 		$83K Buy
+5,200
New +$81.1K 0.01% 802
2022
Q1 		– Sell
-200
Closed -$4K – 1443
2021
Q4 		$4K Buy
+200
New +$5.46K 0.01% 981

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Aquatic Capital Management's RCKT Position: Q2 2026 in Review

Aquatic Capital Management sold out of Rocket Pharmaceuticals (RCKT) in Q2 2026, closing a stake of 58,166 shares — an estimated $208K sold.

Aquatic Capital Management first reported a position in RCKT in Q4 2021 and held it in 6 quarters. The position peaked at $353K in Q1 2024. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Aquatic Capital Management reported no remaining Rocket Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 58,166 Rocket Pharmaceuticals shares in Q2 2026, an estimated $208K.
  • Aquatic Capital Management first reported a position in Rocket Pharmaceuticals in Q4 2021 and held it in 6 quarters.
  • Aquatic Capital Management's Rocket Pharmaceuticals position peaked at $353K in Q1 2024.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.